-
Company Insights
Innovation and Patenting activity of Chong Kun Dang Pharmaceutical Corporation Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Chong Kun Dang Pharmaceutical Corporation Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report...
-
Company Insights
Innovation and Patenting activity of Chong Kun Dang Holdings Corp Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Chong Kun Dang Holdings Corp Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report...
-
Company Insights
Innovation and Patenting activity of Sam Chun Dang Pharm Co Ltd Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Sam Chun Dang Pharm Co Ltd Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CKD-331 in Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CKD-331 in Hypertension report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CKD-331 in Hypertension Drug Details: CKD-331 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CKD-331 in Hyperlipidemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CKD-331 in Hyperlipidemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CKD-331 in Hyperlipidemia Drug Details: CKD-331 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CKD-846 in Benign Prostatic Hyperplasia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CKD-846 in Benign Prostatic Hyperplasia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CKD-846 in Benign Prostatic Hyperplasia Drug Details: CKD-846 is under development...
-
Product Insights
NewAngina (Angina Pectoris) – Drugs In Development, 2024
Empower your strategies with our Angina (Angina Pectoris) – Drugs In Development, 2024 report and make more profitable business decisions. Angina pectoris is a term that describes chest pain caused by myocardial ischemia. It usually occurs with exertion and is relieved by rest. Angina generally is a symptom of coronary artery disease. In most severe cases, it occurs with minimal effort or at rest. Symptoms include anxiety, increased or irregular heart rate, paleness and cold sweat, and a feeling of doom....
-
Product Insights
NewUremic (Renal) Pruritus – Drugs In Development, 2024
Empower your strategies with our Uremic (Renal) Pruritus – Drugs In Development, 2024 report and make more profitable business decisions. Uremic pruritis is a condition where there is presence of excess urea in the blood associated with itchiness (pruritis). It is associated with chronic kidney disease (CKD). Most common in end stage CKD and patients on hemodialysis. Underlying diseases (CKD), diabetes, inflammation, uremic toxins are common triggering factors affecting 20-25% of body surface area and is associated with itchiness, secondary skin...
-
Product Insights
NewMale Hypogonadism – Drugs In Development, 2024
Empower your strategies with our Male Hypogonadism – Drugs In Development, 2024 report and make more profitable business decisions. Male hypogonadism is a condition in which the body doesn't produce enough testosterone. Symptoms include fatigue, hot flashes, infertility, decrease in muscle mass, and loss of bone mass (osteoporosis). Risk factors for hypogonadism include HIV/AIDS, Klinefelter syndrome, Kallmann syndrome, injury to testicles, and untreated sleep apnea. Treatment includes hormone replacement. The Male Hypogonadism drugs in development market research report provide comprehensive information...
-
Product Insights
NewMenopausal Disorders – Drugs In Development, 2024
Empower your strategies with our Menopausal Disorders – Drugs In Development, 2024 report and make more profitable business decisions. Menopausal disorders encompass a range of symptoms and health issues that arise during and after menopause, a natural biological process marking the end of a woman's reproductive years. Common menopausal symptoms include hot flashes, night sweats, mood swings, and changes in sleep patterns. Hormonal fluctuations during this transition can also lead to conditions such as vaginal atrophy, affecting the genital tissues, and...